|
SUCCESS OF MOUSE STUDY WARRANTS IMMEDIATE CLINICAL TRIALS, SAY RESEARCHERS
09 January 2007 - Duke University
| In studies with mice, treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias, autoimmune diseases and transplant rejection, according to immunologists at Duke University Medical Center. |
In studies with mice, treatment with a new monoclonal antibody that targets immune system B cells has shown considerable promise for treating leukemias, autoimmune diseases and transplant rejection, according to immunologists at Duke University Medical Center.
http://www.duke.edu
About: Duke University
Tracing its origins to a rural schoolhouse in 1838, Duke University has evolved into one of the world's leading institutions for education, research and medical care. |
More News:
• For January 2007
• From Duke University
• For University
|
